Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ChampionX Corp C.CHX


Primary Symbol: CHX

ChampionX Corporation is engaged in offering chemistry solutions, artificial lift systems, and engineered equipment and technologies that help companies drill for and produce oil and gas. The Company’s Production Chemical Technologies segment offers products and services that cover a range of onshore, offshore, and oil sands chemical solutions in production and midstream operations. Its Production & Automation Technologies segment offers products, technologies, and services that facilitate the extraction of oil and gas through artificial lift and digital automation applications. It designs, manufactures, markets a full range of artificial lift equipment, end-to-end automation, and digital solutions, and other production equipment and emissions monitoring solutions. Its Drilling Technologies segment offers polycrystalline diamond cutter (PDC) inserts, bearings, valves, and mining tools. Its Reservoir Chemical Technologies segment offers chemistry-oriented solutions and technologies.


NDAQ:CHX - Post by User

Post by hockeytownon Feb 02, 2017 8:03pm
160 Views
Post# 25792623

Private Placement closed

Private Placement closed

 

ChroMedX closes $611,050 final tranche of financing

 

2017-02-02 16:28 ET - News Release

 

An anonymous director reports

CHROMEDX ANNOUNCES CLOSING OF PRIVATE PLACEMENT

ChroMedX Corp. has closed the second and final tranche of its previously announced non-brokered private placement by issuing 4,073,667 units at a price of 15 cents per unit for aggregate gross proceeds of $611,050.05. Each unit comprises one common share of the company and one common share purchase warrant. Each warrant entitles the holder thereof to acquire one common share at a price of 20 cents for a period of 18 months from the closing of the offering.

The securities issued in connection with the offering will be subject to a hold period of four months plus a day from the date of issuance pursuant to applicable securities laws. The proceeds of the offering will be used for developing prototypes, marketing and general working capital purposes.

Certain eligible persons were paid a cash commission equal to 8 per cent of the proceeds raised from subscribers introduced to the company by such finder and were also issued broker warrants equal to 8 per cent of the securities purchased by such subscribers. Each broker warrant entitles the holder thereof to purchase one common share at a price of 20 cents for a period of 18 months from the closing of the offering.

About ChroMedX Corp.

ChroMedX is a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing. The devices are protected by the company's issued and pending patents, dealing with blood collection, analysis and plasma/serum processing.

We seek Safe Harbor.

 
<< Previous
Bullboard Posts
Next >>